Ronald Weigel
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Effect of Vandetanib on Cellular Markers in Invasive Breast Cancer (NCT01934335) | Ronald Weigel | 2013-10-01 |
Track Ronald Weigel automatically
Every clearance here is in the API, with alerts when new ones post.